Severe opioid withdrawal precipitated by Vivitrol®
Volume: 36, Issue: 6, Pages: 1128.e1 - 1128.e2
Published: Jun 1, 2018
Abstract
The risk of severe precipitated opioid withdrawal (POW) is amplified when precipitated by a long-acting opioid antagonist. IM extended release naltrexone (XRNTX;Vivitrol®) is an FDA approved therapy to prevent relapse of opioid and alcohol abuse. Two cases of precipitated opioid withdrawal from XRNTX are presented that illustrate different patient reactions to POW. A 56-year-old woman developed a hypertensive emergency and required continuous...
Paper Details
Title
Severe opioid withdrawal precipitated by Vivitrol®
Published Date
Jun 1, 2018
Volume
36
Issue
6
Pages
1128.e1 - 1128.e2
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History